Adial Pharmaceuticals (ADIL)
(Delayed Data from NSDQ)
$0.43 USD
+0.02 (4.48%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.42 -0.01 (-3.23%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ADIL 0.43 +0.02(4.48%)
Will ADIL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADIL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADIL
Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why
Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know
ADIL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ADIL
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's After-Market Session